Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 43: 1665-1667, 1997;
This Article
Right arrow Extract Freely available
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Delanghe, J.
Right arrow Articles by Van Duynslaegher, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Delanghe, J.
Right arrow Articles by Van Duynslaegher, J.
Related Collections
Right arrow Pediatric Clinical Chemistry
Right arrow Proteomics and Protein Markers
(Clinical Chemistry. 1997;43:1665-1667.)
© 1997 American Association for Clinical Chemistry, Inc.


Technical Briefs

Absence of Serum Alanine Aminotransferase Activity in a Neonate

Joris Delanghe1,a, Hilde Vlaminck2, Dirk Bernard1, Eddy Robberecht2, Marleen Praet3, Marc De Buyzere1, Jozef Quatacker3, Nadine Van Roy4 and Johan Van Duynslaegher5

1 Lab. of Clin. Chem. and Depts. of
2 Pediatrics,
3 Pathol., and
4 Med. Genetics, University Hosp., B-9000 Gent, Belgium, and
5 Dept. of Pediatrics, ASZ, B-9300 Aalst, Belgium;
a address for correspondence: Central Lab., 1B2, University Hosp. Gent, De Pintelaan 185, B-9000 Gent, Belgium, fax ##32/9/240.49.85, e-mail joris.delanghe{at}rug.ac.be

Oral–facial–digital syndrome II (Mohr syndrome) is an autosomal recessive syndrome characterized by bilateral polysyndactylia of the halluces, bilateral hexadactylia of the hands, lobed tongue, and multiple oral frenula and peculiar facies (1). Hitherto, no biochemical abnormalities have been associated with this syndrome.

The propositus is a Caucasian boy (mixed Flemish/German descent) born from an incestuous father–daughter relation. During the pregnancy, a marked intrauterine growth retardation was observed. At delivery, after a pregnancy of 40 weeks, the infant's height (35.0 cm), weight (2400 g), and head circumference (28.2 cm) were all below the first percentile. Diagnosis of Mohr syndrome was confirmed by the observation of polydactylia of the feet; syndactylia of toes 1–2 and 3–4 of both feet; bifid tongue tip with broad, short uvula; bilateral hexadactylia of the hands; and a peculiar facies with micrognathia and microcephaly. Furthermore, the vertebral body T11 was bifurcated and transfontanellar ultrasonography of the brain revealed slightly dilated lateral and third ventricles. Shortly after birth, transient tachypnea and feeding difficulties were present, which gradually disappeared. At the age of 6 weeks, a persistent jaundice was noticed: serum total bilirubin 166 µmol/L (reference interval 1–19 µmol/L) and conjugated bilirubin 115 µmol/L (reference interval 0–14 µmol/L). Stools did not contain bile pigments. Aspartate aminotransferase (AST) (240 U/L, reference interval 16–58 U/L), alkaline phosphatase (399 U/L, reference interval 225–370 U/L), and {gamma}-glutamyltransferase (782 U/L, reference interval 11–49 U/L) were increased. L-Alanine aminotransferase (ALT, EC 2.6.1.2) activity (<1 U/L, reference interval 9–51 U/L) remained undetectable even after in vitro addition of pyridoxal-5'-phosphate (P-5'-P) to exclude ALT cofactor deficiency. Total protein (60 g/L) and albumin concentrations (41 g/L) were normal. Serum creatinine was 36 µmol/L (reference interval 27–53 µmol/L). Inflammatory variables C-reactive protein (14.1 mg/L, reference interval <5 mg/L) and leukocyte count (20.7 x 109/L, reference interval 7.0–15.3 x 109/L) were increased. All test results for infectious etiologies were normal. Serological investigations (antibodies against Toxoplasma gondii, Epstein Barr virus, rubella virus, cytomegalovirus, herpes simplex virus, Treponema pallidum, hepatitis B and C viruses, enterovirus, Coxsackie virus) were negative. On ultrasonography the liver was homogeneously dense and not enlarged. Bile ducts were not dilated. Hepatic uptake and excretion of 99-mTc-imino diacetic acid were both reduced. Cholangiography showed a patent extrahepatic bile tree. At week 7 the patient had to be hospitalized and biochemical variables were determined on admission. One week later, stools became colored under ursodeoxycholic acid therapy (50 mg/day), and cholestasis gradually diminished, but a progressive coagulopathy indicated progression of hepatocellular dysfunction. The prothrombin time was only 6% (reference interval 50–100%), resulting in an international normalized ratio of 35.3 (reference interval <2.0). The activated partial thromboplastin time was >180 s (reference interval 22–37 s). Plasma fibrinogen was 4.22 g/L (reference interval 1.80–4.55 g/L). On the 11th day of hospitalization, at the age of 10 weeks, the patient died because of a progressive liver failure. A postmortem examination was carried out. All investigations were performed in accordance with the Helsinki declaration of 1975 as revised in 1983.

The pedigree of the propositus (no. 1) is presented in Fig. 1 . The parents are extremely consanguineous (father being maternal grandfather), resulting in an inbreeding coefficient (F) of 0.25 (2). The patient's brother (no. 2) suffered from a complex congenital heart defect (ventricle septum defect, arteria pulmonalis stenosis, coarctatio aortae) and a sliding-type hernia diaphragmatica. He died at the age of 2 years from septicemia after surgical correction of the congenital defect. Nephew (no. 3), also born from a consanguineous relation, showed similar skeletal malformations and was also diagnosed as having Mohr syndrome. Both the propositus' brother and nephew had normal liver function, and liver enzymes including ALT were within reference limits.



View larger version (18K):
[in this window]
[in a new window]
 
Figure 1. Pedigree of the propositus: 1, propositus; 2, brother who died from a complex congenital heart disease; 3, nephew with normal ALT activity in serum and Mohr syndrome.

Cytogenetic analysis on phytohemagglutinin-stimulated lymphocytes revealed a normal karyotype.

Serum ALT activity of the propositus' parents and his brother and sisters was within reference limits. At autopsy, liver tissue from the propositus was obtained and an extract was prepared according to Tsung (3). ALT activity in the liver extract was undetectable (<1 U/g of wet tissue, reference interval 50–70 U/g), whereas normal activities of alkaline phosphatase, {gamma}-glutamyltranspeptidase, and AST were found. ALT activities in serum and liver tissue extract were measured according to the IFCC (4)(5) at 37 °C on a Hitachi 747 analyzer with reagents supplied by Boehringer Mannheim. In vitro addition of the ALT coenzyme P-5'-P (final concentration: 4.5 mmol/L) (6) did not result in an increase of serum or liver tissue extract ALT activity. Presence of ALT-inhibiting substances in the patient's serum was investigated with a mixing experiment in which the patient's serum was incubated at 37 °C for 10 min with an equal amount of pooled serum originating from healthy blood donors. The measured ALT activity of the mixture corresponded to the theoretically expected activity and thus did not reveal the presence of an ALT inhibitor in the patient's serum.

Light microscopy revealed portal tracts with hypoplasia of the interlobar bile ducts and a discrete ductular metaplasia surrounded by biliary fibrosis. In numerous hepatocytes accumulation of bile pigments was present. A pseudoglandular arrangement of the hepatocytes occurred. Electron microscopy of the hepatocytes revealed mitochondria with a condensed matrix and a concomitant expansion of the space between the inner and outer membranes. The endoplasmic reticulum showed dilatation of the saccules. These were filled with a medium-dense protein-containing material. Bile pigments were accumulated in the cytoplasm. Postmortem examination of the liver revealed secondary biliary fibrosis. No morphological alterations were observed at the cerebrum, cerebellum, and hippocampus.

Oral–facial–digital syndrome type II (Mohr syndrome) is a rare malformation syndrome, mainly involving the musculoskeletal system. The musculoskeletal malformations found in the propositus are diagnostic for this syndrome. The presence of two nephews with Mohr syndrome within an extremely consanguineous family is suggestive of an autosomal recessive inheritance of this condition (1)(7). Neither liver and bile duct abnormalities, nor the absence of ALT activity as observed in the propositus, have been reported to be a part of this syndrome (1)(7). In the propositus, a hepatocellular dysfunction was present, as evidenced by the increased liver enzyme activities in the serum and the present coagulopathy. In contrast, ALT activity in serum was undetectable. ALT activity is found in many cell types, but the highest activity is found in liver and kidney tissue (5). ALT plays a role in the transfer of amino groups from alanine to {alpha}-ketoglutaric acid. This reaction provides a source of nitrogen for the urea cycle (5)(8). Earlier, Cooper et al. (9)(10) demonstrated in a rat liver model the important role of ALT in homeostasis by its high capacity to shuttle nitrogen as needed. The lack of ALT could interfere with this nitrogen shuttling and also deprive the liver of an energy source. Considering these data, it might not be surprising that liver failure occurred in this patient.

Enzyme deficiencies theoretically can be caused by an absence of enzyme molecules, by the absence of a coenzyme, or by the presence of inhibitors. Absence of the coenzyme P-5'-P and its amino analog, pyridoxamine-5'-phosphate, and the presence of inhibitors could be excluded in the propositus. Most likely, the propositus had an ALT deficiency due to absence of active enzyme molecules. Earlier, acquired deficiency of ALT was described in hemodialysis patients (11)(12). In these patients, this deficiency has been partly attributed to a deficiency of the ALT cofactor, P-5'-P. Endogeneous inhibitors of ALT have not been described yet. Also, a congenital absence of ALT in serum or tissue has not been reported until now. Thus, primary ALT deficiency is an extremely rare condition.

The isolated finding of ALT deficiency in the propositus suggests that both parents must have been heterozygous for ALT deficiency and therefore points towards an autosomal recessive inheritance. The finding of a nephew with Mohr syndrome but without ALT deficiency suggests that both conditions are unlinked, and that the propositus has inherited Mohr syndrome as a result of the extreme relatedness of the parents. However, the finding of an isolated ALT deficiency in the propositus should not exclude that this ALT deficiency is part of a hitherto undescribed general metabolic disorder or occurs in association with the observed morphological abnormalities in the liver tissue of our patient.

Electron microscopy of the liver showed an endoplasmic reticulum with web-like cannalicular appearance and vesicular dilatation. The changes of the endoplasmic reticulum are suggestive of a defect in protein processing. The mitochondria were characterized by a variable morphology with a tendency to angular widening. In this respect the changes in the mitochondria can be expected to be secondary changes reflecting the condition of the hepatocyte. A marked intrahepatic cholestasis was found, as evidenced by the histological and biochemical analysis (accumulation of bile pigments and increased bilirubin and alkaline phosphatase activity) and nuclear imaging. These morphological findings have not been associated earlier with Mohr syndrome and are hitherto undescribed in the literature. As ALT is mainly a cytosolic enzyme and the morphological changes concern the endoplasmic reticulum and mitchondria, the patient had an undescribed complex congenital syndrome.

In conclusion, we report the first case of a congenital ALT deficiency associated with endoplasmic reticulum and mitochondrial morphological abnormalities in liver tissue in a patient with Mohr syndrome born from an extremely consanguineous relation.


References

  1. Toriello HV. Heterogeneity and variability in the oral–facial–digital syndromes. Am J Med Genet 1988;4(Suppl):s149-ss59.
  2. Stern C. Consanguinity. Stern C eds. Principles of human genetics 3rd ed. 1973:468-501 Freeman and Co. San Francisco. .
  3. Tsung S. Creatine kinase isoenzyme patterns in human tissue obtained at surgery. Clin Chem 1976;22:173-175. [Abstract/Free Full Text]
  4. Bergmeyer HU, Hørder M, Rej R. Approved recommendation (1985) on IFCC methods for the measurement of catalytic concentrations of enzymes: Part 3. IFCC method for alanine aminotransferase (L-alanine:oxoglutarate aminotransferase, EC 2.6.1.2.). J Clin Chem Clin Biochem 1986;24:481-492. [ISI][Medline] [Order article via Infotrieve]
  5. Moss D, Henderson R. Enzymes. Burtis A Ashwood E eds. Tietz textbook of clinical chemistry 2nd ed. 1994:735-896 W.B. Saunders Philadelphia. .
  6. Hørder M, Rej R. Alanine aminotransferase (glutamate pyruvate transaminase). Bergmeyer H eds. 5th ed. Methods of enzymatic analysis 1983;Vol 3:444-456 Verlag Chemie Weinheim, Germany. .
  7. Neri G, Gurrieri F, Genuardi M. Oral–facial–skeletal syndromes [Editorial]. Am J Med Gen 1995;59:365-368. [ISI][Medline] [Order article via Infotrieve]
  8. Scriver CR, Gibson KM. Disorders of ß- and {gamma}-amino acids in free and peptide-linked forms. Scriver CR Beaudet AL Sly WS Valle D eds. The metabolic and molecular bases of inherited disease 7th ed. 1995:1349-1367 McGraw-Hill New York. .
  9. Cooper AJL, Nieves E, Coleman AE, Filc-De Ricco S, Gelbard AS. Short-term metabolic fate of [13N]ammonia in rat liver in vivo. J Biol Chem 1987;262:1073-1080. [Abstract/Free Full Text]
  10. Cooper AJL, Nieves E, Rosenspire KC, Filc-De Ricco S, Gelbard AS, Brusilow SW. Short-term metabolic fate of 13N-labeled glutamate, alanine, and glutamine(amide) in rat liver. J Biol Chem 1988;263:12268-12273. [Abstract/Free Full Text]
  11. Ono K, Ono T, Matsumata T. The pathogenesis of decreased aspartate aminotransferase and alanine aminotransferase activity in the plasma of hemodialysis patients: the role of vitamin B6 deficiency. Clin Nephrol 1995;43:405-408. [ISI][Medline] [Order article via Infotrieve]
  12. Yasuda K, Okuda K, Endo N, Ishiwatari Y, Ikeda R, Hayashi H, et al. Hypoaminotransferasemia in patients undergoing long-term hemodialysis: clinical and biochemical appraisal. Gastroenterology 1995;109:1295-1300. [ISI][Medline] [Order article via Infotrieve]




This Article
Right arrow Extract Freely available
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Delanghe, J.
Right arrow Articles by Van Duynslaegher, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Delanghe, J.
Right arrow Articles by Van Duynslaegher, J.
Related Collections
Right arrow Pediatric Clinical Chemistry
Right arrow Proteomics and Protein Markers


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS